Toshiba (TYO:6502) said yesterday that it inked a deal to sell its medical device business to Canon (NYSE:CAJ) for $5.9 billion, as the U.S. Justice Dept. and the SEC probed the accounting practices in its U.S. businesses, and today said it plans to lay off an additional 3,000 workers. Toshiba last week granted Canon exclusive negotiating rights to buy […]
Fujifilm Holdings (TSE:4901), which lost out last week to Canon (NYSE:CAJ) in the race to be picked as preferred bidder for conglomerate Toshiba‘s (TYO:6502) medical device business, questioned Toshiba today on the timing of the deal for Toshiba Medical Systems. In a letter to embattled Toshiba, Fujifilm cited media reports saying profits from the sale would contribute to Toshiba’s finances […]
Canon (NYSE:CAJ) beat out Fujifilm Holdings (TSE:4901) for the exclusive right to negotiate with Toshiba (TYO:6502) for its medical device business, the embattled Japanese conglomerate said today. “Toshiba has carried out a close evaluation of the overall proposals received from companies that expressed an interest in acquiring [Toshiba Medical Systems Corp.], including their appraisal of TMSC’s value and the feasibility […]
Fujifilm Holdings (TSE:4901) and Canon (NYSE:CAJ) are at the head of the crowd looking to pick up Toshiba‘s (TYO:6502) medical device business, according to The Wall Street Journal, at a price possibly reaching $6 billion. The 2nd round of bidding for the division is slated to close Friday, with Toshiba likely selecting a single bidder to enter exclusive […]
A bidding war for Toshiba (TYO:6502) subsidiary Toshiba Medical is reportedly heating up among a slew of private equity players and rival corporations. Toshiba, which said last month that it’s seeking outside investors to buy a stake in the healthcare business amid laying off nearly 7,000 workers, wants to focus on its core nuclear energy and chip businesses. Private equity shops KKR and Bain […]
CAZ Investments raised a nearly $29 million funding round it plans to use to back medical companies that already have products on the market.
The Houston-based asset management firm reeled in $28.7 million from 61 unnamed investors, according to a regulatory filing.
CAZ Investments chairman Christopher Zook said the firm plans to use the cash to invest in commercialized companies.
Medtronic Inc. (NYSE:MDT) won FDA clearance for its next generation iPro2 Professional continuous glucose monitor.
The iPro2 Professional is a clinician-owned device that collects glucose data from a sensor inserted into a patient’s skin.
The device tracks the patient’s glucose levels for 3 days, collecting data as many as 288 times each day. The information may provide insight into how diet, medication and daily activities affect a patient’s glucose levels.
St. Jude Medical Inc. (NYSE:STJ) got the FDA’s green light for the U.S. market’s first combined FFR/OCT blood vessel imaging system for diagnosis and treatment of coronary artery disease.
The Ilumien system combines St. Jude’s PressureWire Aeris wireless fractional flow reserve imaging technology, which allows physicians to visualize blood vessel characteristics, and its Extreme Resolution optical coherence tomography, which helps evaluate the severity of blood flow blockages in coronary arteries.